By July 2013, a handful of key immunohistochemical (IHC) stains (Ki-67, p16, LANA, CD3, CD20, CD45, ER, and PR) were implemented primarily to support the KCH Lymphoma Study, an observational clinical cohort of lymphoproliferative disorders (LPDs) that continues to enroll to this day (3). Here, MKI67 is linked to lymphoma.